Utah Medical Products
UTMD
76 hedge funds and large institutions have $159M invested in Utah Medical Products in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 2 closing their positions.
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
36% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 22
12% more funds holding
Funds holding: 68 → 76 (+8)
1% more capital invested
Capital invested by funds: $158M → $159M (+$1.12M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Analytic Investors
Los Angeles,
California
|
+$1.05M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$696K |
| 3 |
Two Sigma Investments
New York
|
+$450K |
| 4 |
Renaissance Technologies
New York
|
+$437K |
| 5 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
+$406K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$3.15M |
| 2 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$1.65M |
| 3 |
MDCM
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
|
-$822K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$634K |
| 5 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$599K |
UTMD Hedge Fund Activity: Q2 2016 in Review
76 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2016, worth a combined $159M — up 0.71% from $158M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new UTMD positions and 2 closed out — a net gain of 9 holders — while 30 added to existing stakes and 22 trimmed.
The largest buyer was Analytic Investors, opening a new position worth an estimated $1.05M. The largest seller was American Century Companies, cutting an estimated $3.15M.
- 76 institutional investors held Utah Medical Products (UTMD) as of Q2 2016, up from 68 in Q1 2016.
- Funds reported $159M of Utah Medical Products stock for Q2 2016, up 0.71% quarter-over-quarter.
- 11 funds opened new Utah Medical Products positions in Q2 2016 and 2 closed out, a net change of +9 holders.
- The largest Utah Medical Products buyer in Q2 2016 was Analytic Investors, an estimated $1.05M added.
- The largest Utah Medical Products seller in Q2 2016 was American Century Companies, an estimated $3.15M sold.
Based on aggregated 13F filings for Q2 2016.